Active, Not Recruiting
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
NCT06672055
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- Pinnacle Research Group Anniston, Alabama, United States
- Core Clinical Trials - Central Alabama Research LLC Birmingham, Alabama, United States
- Coastal Clinical Research Mobile, Alabama, United States
- Avacare - Lenzmeier Family Medicine Glendale, Arizona, United States